EUVIMEDEUVIMED entdecken
Crossref

Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus

Andreas F Wendel, Robin Otchwemah, Franziska Layer-Nicolaou, Frauke Mattner, Carlos J Tellez-Castillo, Robert Skov, Henrik Oberländer, Guido Werner, Birgit Strommenger

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.06.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Andreas F Wendel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Cologne, Germany; Division of Hygiene and Environmental…. Hauptthemen laut MEDLINE: Daptomycin, Methicillin-Resistant Staphylococcus aureus, Anti-Infective Agents, Local, Staphylococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Because of a steady increase in the detection of daptomycin-resistant (DAP-R) Staphylococcus aureus at three medical centres in Cologne, Germany, molecular surveillance was established from June 2016 to June 2018 to investigate the causes of the emergence and spread of respective isolates. Seventy-five S. aureus isolates, both DAP-R and DAP-susceptible, were collected from 42 patients for further analysis. METHODS: Broth microdilution was used to determine the MICs for DAP and polyhexamethylene biguanide/polyhexanide (PHMB). To investigate the effect of PHMB on the development of DAP resistance, we performed selection experiments with PHMB. All isolates studied were subjected to whole-genome sequencing. Epidemiological, clinical, microbiological and molecular data were analysed comparatively. RESULTS: Acquisition of DAP resistance was mainly observed in patients with acute and chronic wounds (40/42, 96.2%) treated with antiseptic (32/42, 76.2%) rather than systemic antibiotic therapy using DAP or vancomycin (7/42, 16.7%). DAP-R S. aureus had a diverse genetic background; however, within individual patients, isolates were closely related. At least three potential transmission events were detected. Most DAP-R isolates had concomitant elevated MICs for PHMB (50/54, 92.6%), and in vitro selection experiments confirmed that PHMB treatment is capable of generating DAP resistance. DAP resistance could be linked to 12 different polymorphisms in the mprF gene in the majority of clinical isolates (52/54, 96.3%) as well as in all in vitro selected strains. DISCUSSION: DAP resistance in S. aureus can occur independently of prior antibiotic therapy and can be selected by PHMB. Therefore, wound treatment with PHMB may trigger individual resistance development associated with gain-of-function mutations in the mprF gene.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinMethicillin-Resistant Staphylococcus aureusAnti-Infective Agents, LocalStaphylococcal InfectionsHumansStaphylococcus aureusPolymorphism, Single NucleotideAnti-Bacterial AgentsMicrobial Sensitivity TestsBacterial Proteins

Stichwörter der Autor:innen

DaptomycinPolyhexanideResistanceS. aureusmprF

Substanzen

DaptomycinAnti-Infective Agents, LocalAnti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Institute of Hygiene, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Cologne, Germany; Division of Hygiene and Environmental Medicine, Department of Human Medicine, Faculty of Health, Witten/Her…
  • Robert Koch Institute, Department of Infectious Diseases, Division 'Nosocomial Pathogens and Antibiotic Resistances', National Reference Centre for Staphylococci and Enterococci, Wernigerode, Germany.
  • Department of Clinical Microbiology, MVZ Synlab Leverkusen GmbH, Köln-Merheim, Germany.
  • Department of Plastic Surgery, Hand Surgery, Burn Centre, Cologne Merheim Medical Centre, University Hospital of Witten/Herdecke, Cologne, Germany.
  • Robert Koch Institute, Department of Infectious Diseases, Division 'Nosocomial Pathogens and Antibiotic Resistances', National Reference Centre for Staphylococci and Enterococci, Wernigerode, Germany. Electronic address…

Zitieren

APA

Wendel, A. F., Otchwemah, R., Layer-Nicolaou, F., Mattner, F., Tellez-Castillo, C. J., Skov, R., Oberländer, H., Werner, G., & Strommenger, B. (2023). Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.06.007

Vancouver

Wendel AF, Otchwemah R, Layer-Nicolaou F, Mattner F, Tellez-Castillo CJ, Skov R, et al. Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.06.007

BibTeX
@article{Wendel2023,
  author = {Wendel, Andreas F and Otchwemah, Robin and Layer-Nicolaou, Franziska and Mattner, Frauke and Tellez-Castillo, Carlos J and Skov, Robert and Oberländer, Henrik and Werner, Guido and Strommenger, Birgit},
  title = {Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.06.007}
}
Kostenlos starten →